Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2025-12-24 @ 1:17 PM
NCT ID:
NCT02156895
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed as advanced RCC after failure of one prior systemic therapy.
Exclusion Criteria:
* Any patient who does not agree that Pfizer or companies working on behalf of Pfizer can use his/her information.
* Patients with hypersensitivity to axitinib or to any other component of INLYTA® .
* Patients under 18.
* Pregnant women.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02156895
Study Brief:
Protocol Section:
NCT02156895